FTC Hytrin Order Clears Path For Four Generics; Cardizem CD Case Filed

Geneva's settlement with the Federal Trade Commission regarding generic terazosin (Hytrin) could open up the market for up to four new entrants.

More from Archive

More from Pink Sheet